Status:
COMPLETED
Evaluation of the Unstimulated Whole Saliva Flow During and After Radiotherapy, With the Use HcT20
Lead Sponsor:
UPECLIN HC FM Botucatu Unesp
Conditions:
Abnormalities, Radiation-Induced
Eligibility:
All Genders
40-82 years
Phase:
PHASE2
Brief Summary
The aim of this report was to evaluate the unstimulated whole saliva flow in patients with head and neck cancers during and after the exclusive radiotherapy with an association of lauryl-diethylene-gl...
Detailed Description
Thirty one patient were observed and treated at Oral Cancer Center - Brazil, between March 1997 and June 2006, distributed into two groups the following way: Group I composed of seventeen patients who...
Eligibility Criteria
Inclusion
- presented lesions with primary site in the mouth, oropharynx or larynx with diagnosis of squamous cell carcinoma.
- the patients were edentulous
- The patients included were guided for exclusive radiotherapeutic treatment.
- To be accepted in this study, it was established as a requirement that the fields of irradiation included in all occasions the major salivary glands, partially or totally.
Exclusion
- Patients who used medical drugs wich could interfere in the salivary flow rate, with teeth, mucositis or any other alteration of the oral mucosa after radiotherapy was excluded.
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00741754
Start Date
June 1 2005
End Date
July 1 2006
Last Update
April 1 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dental School - São Paulo State University
Araçatuba, São Paulo, Brazil, 16015-050